Westlake Chemical Partners LP Announces Third Quarter 2026 Results
Distribution coverage improved to 1.09x as lower maintenance capital expenditures and higher sales volume supported distributable cash flow.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Westlake Chemical Partners (NYSE: WLKP) reported third-quarter 2026 net income attributable to the Partnership of $16.219 million, up year over year. Earnings per unit rose to $0.46 from $0.42, while net sales increased to $314.459 million from $308.898 million.
Operating cash flow was $122.2 million, up $17.0 million year over year but down $7.6 million sequentially, reflecting working-capital changes. MLP distributable cash flow, a non-GAAP measure of cash available for distributions, rose to $17.978 million from $14.886 million a year earlier. Trailing twelve-month distribution coverage improved to 1.09x from 1.04x at the second quarter's end.
The quarterly distribution remains $0.4714 per common unit, payable December 1, 2026, to holders of record November 13. Nine-month attributable net income increased to $44.626 million from $34.159 million.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointThird-quarter attributable net income rose to $16.219 million from $14.653 million a year earlier.
- Moderate pointThird-quarter net sales increased to $314.459 million from $308.898 million a year earlier.
- Moderate pointThird-quarter operating cash flow of $122.2 million rose $17.0 million annually but fell $7.6 million sequentially.
- Moderate pointThird-quarter MLP distributable cash flow increased to $17.978 million from $14.886 million a year earlier.
- Moderate pointTrailing twelve-month distribution coverage improved to 1.09x from 1.04x at the second quarter's end.
17 minor points
- Minor pointThird-quarter earnings per unit increased to $0.46 from $0.42 a year earlier.
- Minor pointThird-party quarterly sales increased to $52.524 million from $32.359 million a year earlier.
- Minor pointThird-quarter gross profit rose to $103.896 million from $99.423 million a year earlier.
- Minor pointThird-quarter operating income increased to $95.560 million from $91.979 million a year earlier.
- Minor pointThird-quarter interest expense fell to $5.110 million from $5.947 million a year earlier.
- Minor pointThird-quarter EBITDA increased to $128.329 million from $126.075 million a year earlier.
- Minor pointSequential attributable net income increased $2.0 million, supported by higher production and sales volume.
- Minor pointSequential MLP distributable cash flow increased $0.4 million, supported by higher production and sales volume.
- Minor pointNine-month net sales increased to $917.234 million from $843.646 million a year earlier.
- Minor pointNine-month attributable net income increased to $44.626 million from $34.159 million a year earlier.
- Minor pointNine-month earnings per unit rose to $1.27 from $0.97 a year earlier.
- Minor pointNine-month EBITDA increased to $372.232 million from $325.487 million a year earlier.
- Minor pointNine-month MLP distributable cash flow rose to $53.500 million from $34.607 million a year earlier.
- Minor pointNine-month operating cash flow increased to $362.205 million from $160.090 million a year earlier.
- Minor pointNine-month capital spending declined to $29.724 million from $69.988 million a year earlier.
- Minor pointCash increased to $47.649 million at September 30, 2026, from $44.269 million at December 31, 2025.
- Minor point. Forward-looking: it has not happened yet and may not happen.Westlake expects earnings and cash flows to continue benefiting from its ethylene sales agreement.
Negative
- Minor pointQuarterly sales to Westlake fell to $261.935 million from $276.539 million a year earlier.
- Minor pointQuarterly selling, general and administrative expenses rose to $8.336 million from $7.444 million a year earlier.
- Minor pointQuarterly cost of sales increased to $210.563 million from $209.475 million a year earlier.
- Minor pointPartners' capital declined to $253.474 million from $258.536 million at December 31, 2025.
News Explained
The agreement specifies a ten-cent-per-pound margin on 95 percent of output; the tax notice states that non-U.S. investors’ distributions are subject to withholding.
The release’s qualified tax notice says brokers and nominees should treat
Under the agreement described, OpCo sells
Key Figures
- Net income attributable
- $16.2 million vs. $14.7 million
- Q3 2026 vs. Q3 2025
- Net income per limited partner unit
- $0.46 per unit
- Q3 2026
- Operating cash flow
- $122.2 million vs. $105.2 million
- Q3 2026 vs. Q3 2025
- MLP distributable cash flow
- $18.0 million vs. $14.9 million
- Q3 2026 vs. Q3 2025
- Trailing twelve-month coverage ratio
- 1.09x vs. 1.04x
- Q3 2026 vs. end of Q2 2026
- Quarterly distribution
- $0.4714 per common unit
- Q3 2026 distribution
- Consecutive quarterly distributions
- 49
- Partnership distribution history
Previous Earnings Reports
-
MLP distributable cash flow rose, and trailing-twelve-month distribution coverage improved from the prior quarter.
-
Same-quarter prior-year results showed lower net income and distributable cash flow amid higher maintenance capital expenditures.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
non-gaap financial
ebitda financial
u.s. gaap financial
noncontrolling interest financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Declared quarterly distribution of
$0.4714 per unit; 49th consecutive quarterly distribution
HOUSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2026 of
Compared to the second quarter, third quarter 2026 net income attributable to the Partnership of
"We were pleased with the Partnership's performance in the third quarter of 2026, with net income, EBITDA and MLP distributable cash flow all increasing from the second quarter," said Jean-Marc Gilson, President and Chief Executive Officer. "Looking forward, we expect our earnings and cash flows to continue to benefit from the stability provided by our ethylene sales agreement with Westlake."
On November 2, 2026, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the third quarter of 2026 of
OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that
The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to: our financing arrangements with Westlake; the timing and results of our turnaround activities; our outlook for third-party ethylene margins; the impact of the conflict in the Middle East on global demand for our products; our expectations regarding feedstock and energy costs, our ability to deliver value, earnings, predictable cash flows and distributions to unitholders; our relationship with Westlake and the benefits and stability of the ethylene sales agreement, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to: operating difficulties or disruptions; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake, including determinations made pursuant to contractual arrangements with Westlake; the effects of legal proceedings; actions of third parties; inclement or hazardous weather conditions; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; inability of our customers to take delivery; fires, explosions or other industrial accidents; political tension and conflict in the Middle East and elsewhere; the supply/demand balance for our products; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC in March 2026, and the Partnership's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which was filed with the SEC in August 2026.
This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (
Use of Non-GAAP Financial Measures
This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.
Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a
Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' third quarter 2026 results will be held Wednesday, November 4, 2026 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register-conf.media-server.com/register/BI3f3870a5aac84874bbbc7d18dbd188bc. A dial-in will be provided upon registration.
The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/so37ydoy and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.
| WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS") | ||||||||||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (In thousands of dollars, except per unit data) | ||||||||||||||||
| Revenue | ||||||||||||||||
| Net sales—Westlake Corporation ("Westlake") | $ | 261,935 | $ | 276,539 | $ | 763,056 | $ | 736,396 | ||||||||
| Net co-products, ethylene and other sales—third parties | 52,524 | 32,359 | 154,178 | 107,250 | ||||||||||||
| Total net sales | 314,459 | 308,898 | 917,234 | 843,646 | ||||||||||||
| Cost of sales | 210,563 | 209,475 | 624,774 | 592,610 | ||||||||||||
| Gross profit | 103,896 | 99,423 | 292,460 | 251,036 | ||||||||||||
| Selling, general and administrative expenses | 8,336 | 7,444 | 23,020 | 21,218 | ||||||||||||
| Income from operations | 95,560 | 91,979 | 269,440 | 229,818 | ||||||||||||
| Other income (expense) | ||||||||||||||||
| Interest expense—Westlake | (5,110) | (5,947) | (15,314) | (17,391) | ||||||||||||
| Other income, net | 565 | 224 | 1,261 | 2,245 | ||||||||||||
| Income before income taxes | 91,015 | 86,256 | 255,387 | 214,672 | ||||||||||||
| Provision for income taxes | 158 | 42 | 513 | 354 | ||||||||||||
| Net income | 90,857 | 86,214 | 254,874 | 214,318 | ||||||||||||
| Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo") | 74,638 | 71,561 | 210,248 | 180,159 | ||||||||||||
| Net income attributable to Westlake Partners | $ | 16,219 | $ | 14,653 | $ | 44,626 | $ | 34,159 | ||||||||
| Net income per limited partner unit attributable to Westlake Partners (basic and diluted) | ||||||||||||||||
| Common units | $ | 0.46 | $ | 0.42 | $ | 1.27 | $ | 0.97 | ||||||||
| Distributions declared per unit | $ | 0.4714 | $ | 0.4714 | $ | 1.4142 | $ | 1.4142 | ||||||||
| MLP distributable cash flow | $ | 17,978 | $ | 14,886 | $ | 53,500 | $ | 34,607 | ||||||||
| Distributions declared | ||||||||||||||||
| Limited partner units—publicly and privately held | $ | 9,961 | $ | 9,958 | $ | 29,877 | $ | 29,867 | ||||||||
| Limited partner units—Westlake | 6,657 | 6,657 | 19,971 | 19,971 | ||||||||||||
| Total distributions declared | $ | 16,618 | $ | 16,615 | $ | 49,848 | $ | 49,838 | ||||||||
| EBITDA | $ | 128,329 | $ | 126,075 | $ | 372,232 | $ | 325,487 | ||||||||
| WESTLAKE CHEMICAL PARTNERS LP | ||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
| (Unaudited) | ||||||||
| September 30, 2026 | December 31, 2025 | |||||||
| (In thousands of dollars) | ||||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 47,649 | $ | 44,269 | ||||
| Receivable under the Investment Management Agreement—Westlake | 65,715 | 23,378 | ||||||
| Accounts receivable, net—Westlake | 43,630 | 63,571 | ||||||
| Accounts receivable, net—third parties | 22,937 | 9,113 | ||||||
| Inventories | 4,462 | 2,769 | ||||||
| Prepaid expenses and other current assets | 77 | 406 | ||||||
| Total current assets | 184,470 | 143,506 | ||||||
| Property, plant and equipment, net | 852,435 | 886,012 | ||||||
| Other assets, net | 188,299 | 227,015 | ||||||
| Total assets | $ | 1,225,204 | $ | 1,256,533 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities (accounts payable and accrued and other liabilities) | $ | 52,451 | $ | 51,301 | ||||
| Long-term debt payable to Westlake | 399,674 | 399,674 | ||||||
| Other liabilities | 2,794 | 3,206 | ||||||
| Total liabilities | 454,919 | 454,181 | ||||||
| Common unitholders—publicly and privately held | 457,877 | 460,848 | ||||||
| Common unitholder—Westlake | 38,169 | 40,260 | ||||||
| General partner—Westlake | (242,572) | (242,572) | ||||||
| Total Westlake Partners partners' capital | 253,474 | 258,536 | ||||||
| Noncontrolling interest in OpCo | 516,811 | 543,816 | ||||||
| Total equity | 770,285 | 802,352 | ||||||
| Total liabilities and equity | $ | 1,225,204 | $ | 1,256,533 | ||||
| WESTLAKE CHEMICAL PARTNERS LP | ||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| (Unaudited) | ||||||||
| Nine Months Ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| (In thousands of dollars) | ||||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | 254,874 | $ | 214,318 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities | ||||||||
| Depreciation and amortization | 101,531 | 93,424 | ||||||
| Net loss on disposition and other | 3,233 | 2,371 | ||||||
| Other balance sheet changes | 2,567 | (150,023) | ||||||
| Net cash provided by operating activities | 362,205 | 160,090 | ||||||
| Cash flows from investing activities | ||||||||
| Additions to property, plant and equipment | (29,724) | (69,988) | ||||||
| Investments with Westlake under the Investment Management Agreement | (42,000) | — | ||||||
| Maturities of investments with Westlake under the Investment Management Agreement | — | 120,000 | ||||||
| Net cash provided by (used for) investing activities | (71,724) | 50,012 | ||||||
| Cash flows from financing activities | ||||||||
| Proceeds from debt payable to Westlake | 124,500 | 135,000 | ||||||
| Repayment of debt payable to Westlake | (124,500) | (135,000) | ||||||
| Distributions to noncontrolling interest retained in OpCo by Westlake | (237,253) | (180,645) | ||||||
| Distributions to unitholders | (49,848) | (49,837) | ||||||
| Net cash used for financing activities | (287,101) | (230,482) | ||||||
| Net increase (decrease) in cash and cash equivalents | 3,380 | (20,380) | ||||||
| Cash and cash equivalents at beginning of period | 44,269 | 58,316 | ||||||
| Cash and cash equivalents at end of period | $ | 47,649 | $ | 37,936 | ||||
| WESTLAKE CHEMICAL PARTNERS LP | ||||||||||||||||||||
| RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME | ||||||||||||||||||||
| AND NET CASH PROVIDED BY OPERATING ACTIVITIES | ||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| Three Months Ended June 30, | Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||
| 2026 | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||
| (In thousands of dollars) | ||||||||||||||||||||
| Net cash provided by operating activities | $ | 129,847 | $ | 122,160 | $ | 105,238 | $ | 362,205 | $ | 160,090 | ||||||||||
| Changes in operating assets and liabilities and other | (47,485) | (31,303) | (19,024) | (107,331) | 54,228 | |||||||||||||||
| Net income | 82,362 | 90,857 | 86,214 | 254,874 | 214,318 | |||||||||||||||
| Add: | ||||||||||||||||||||
| Depreciation, amortization and disposition of property, plant and equipment | 37,155 | 33,261 | 35,660 | 104,776 | 95,703 | |||||||||||||||
| Less: | ||||||||||||||||||||
| Contribution to turnaround reserves | (10,305) | (10,391) | (10,486) | (30,928) | (28,504) | |||||||||||||||
| Maintenance capital expenditures | (11,932) | (15,145) | (24,150) | (34,887) | (65,233) | |||||||||||||||
| Distributable cash flow attributable to noncontrolling interest in OpCo | (79,644) | (80,604) | (72,352) | (240,335) | (181,677) | |||||||||||||||
| MLP distributable cash flow | $ | 17,636 | $ | 17,978 | $ | 14,886 | $ | 53,500 | $ | 34,607 | ||||||||||
| WESTLAKE CHEMICAL PARTNERS LP | ||||||||||||||||||||
| RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH | ||||||||||||||||||||
| PROVIDED BY OPERATING ACTIVITIES | ||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| Three Months Ended June 30, | Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||
| 2026 | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||
| (In thousands of dollars) | ||||||||||||||||||||
| Net cash provided by operating activities | $ | 129,847 | $ | 122,160 | $ | 105,238 | $ | 362,205 | $ | 160,090 | ||||||||||
| Changes in operating assets and liabilities and other | (47,485) | (31,303) | (19,024) | (107,331) | 54,228 | |||||||||||||||
| Net income | 82,362 | 90,857 | 86,214 | 254,874 | 214,318 | |||||||||||||||
| Less: | ||||||||||||||||||||
| Other income, net | 348 | 565 | 224 | 1,261 | 2,245 | |||||||||||||||
| Interest expense—Westlake | (5,119) | (5,110) | (5,947) | (15,314) | (17,391) | |||||||||||||||
| Provision for income taxes | (178) | (158) | (42) | (513) | (354) | |||||||||||||||
| Income from operations | 87,311 | 95,560 | 91,979 | 269,440 | 229,818 | |||||||||||||||
| Add: | ||||||||||||||||||||
| Depreciation and amortization | 35,028 | 32,204 | 33,872 | 101,531 | 93,424 | |||||||||||||||
| Other income, net | 348 | 565 | 224 | 1,261 | 2,245 | |||||||||||||||
| EBITDA | $ | 122,687 | $ | 128,329 | $ | 126,075 | $ | 372,232 | $ | 325,487 | ||||||||||
Contact—(713) 585-2900
Investors—Jeff Holy
Media—L. Benjamin Ederington
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Westlake Chemical Partners' third-quarter 2026 earnings?
Westlake Chemical Partners earned $16.219 million attributable to the Partnership, or $0.46 per limited partner unit, in the third quarter of 2026. That compares with $14.653 million, or $0.42 per unit, a year earlier.
When will WLKP pay its third-quarter 2026 distribution?
The $0.4714 per common unit distribution is payable December 1, 2026, to unitholders of record November 13, 2026. It is the Partnership's 49th consecutive quarterly distribution.
How does Westlake Chemical Partners' ethylene sales agreement work?
The agreement provides for 95% of OpCo's ethylene production to be sold to Westlake at a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures. The Partnership describes the agreement as designed to provide stable and predictable cash flows.
How are WLKP distributions to non-U.S. investors treated for withholding?
Distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate. Brokers and nominees should treat 100.0% of these distributions as income effectively connected with a United States trade or business.
Does WLKP's MLP distributable cash flow include working-capital changes?
MLP distributable cash flow does not reflect working-capital balance changes. It is a non-GAAP measure calculated after subtracting distributable cash flow attributable to Westlake's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder.